TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Integrated Behavioral Activation and HIV Risk Reduction Counseling for Men Who Have Sex With Men (MSM) With Stimulant Abuse
Brief Summary: This study seeks primarily to test, in a two-arm randomized controlled trial (RCT), the efficacy of Project IMPACT, an intervention that integrates Behavioral Activation (BA) with HIV risk reduction (RR) counseling for HIV-uninfected men who have sex with men (MSM) with stimulant use disorder at risk for HIV via sexual behavior. HIV-uninfected MSM with a diagnosis of stimulant use disorder will be equally randomized to one of two study arms: (1) the Project IMPACT intervention, BA-RR counseling, which lasts ten sessions; and (2) the standard of care (SOC) comparison condition, including two equivalent sexual risk-reduction counseling sessions. Participants will be followed for one year post-randomization, with assessments at months four, eight, and 12.


Options:
A: Arm Label: Standard of Care (SOC); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard of Care | Arm Label: Behavioral Activation & Risk Reduction Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: IMPACT | Intervention Type: BEHAVIORAL; Name: IMPACT; Assigned to Arm(s): Behavioral Activation & Risk Reduction Counseling | Intervention Type: BEHAVIORAL; Name: Standard of Care; Assigned to Arm(s): Standard of Care (SOC)
B: Arm Label: A Woman's Path to Recovery (WPR); Type: EXPERIMENTAL; Interventions: Behavioral: A Woman's Path to Recovery | Arm Label: 12-Step Facilitation (TSF); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: 12-Step Facilitation | Intervention Type: BEHAVIORAL; Name: A Woman's Path to Recovery; Assigned to Arm(s): A Woman's Path to Recovery (WPR) | Intervention Type: BEHAVIORAL; Name: 12-Step Facilitation; Assigned to Arm(s): 12-Step Facilitation (TSF)
C: Arm Label: Referral to community resources; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Contingency Management; Type: EXPERIMENTAL; Interventions: Behavioral: Contingency management | Intervention Type: BEHAVIORAL; Name: Contingency management; Assigned to Arm(s): Contingency Management
D: Arm Label: Employment Only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Employment Only | Arm Label: Contingency Management; Type: EXPERIMENTAL; Interventions: Behavioral: Contingency management | Intervention Type: BEHAVIORAL; Name: Contingency management; Assigned to Arm(s): Contingency Management | Intervention Type: BEHAVIORAL; Name: Employment Only; Assigned to Arm(s): Employment Only

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: EVIDENT3 Study: A Randomized, Controlled Clinical Trial to Reduce Inactivity and Caloric Intake in Sedentary, Overweight People Using a Smartphone Application. Study Protocol.
Brief Summary: This is a randomized clinical trial aimed at obese and sedentary subjects aged 20 to 65 years selected in urban primary care centers of 5 centers (Spain). Its objective is to evaluate the effects of the addition of an ICT tool developed for the Smartphone application and a Smartband in support of behavioral and educational recommendations to reduce weight.


Options:
A: Arm Label: Self-monitoring group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: One-on-one Session, Behavioral: Self-monitoring | Arm Label: Self-monitoring+Feedback group; Type: EXPERIMENTAL; Interventions: Behavioral: One-on-one Session, Behavioral: Self-monitoring, Behavioral: Feedback | Intervention Type: BEHAVIORAL; Name: One-on-one Session; Assigned to Arm(s): Self-monitoring group, Self-monitoring+Feedback group | Intervention Type: BEHAVIORAL; Name: Self-monitoring; Assigned to Arm(s): Self-monitoring group, Self-monitoring+Feedback group | Intervention Type: BEHAVIORAL; Name: Feedback; Assigned to Arm(s): Self-monitoring+Feedback group
B: Arm Label: Simple; Type: EXPERIMENTAL; Interventions: Behavioral: Simple | Arm Label: Standard; Type: EXPERIMENTAL; Interventions: Behavioral: Standard | Intervention Type: BEHAVIORAL; Name: Simple; Assigned to Arm(s): Simple | Intervention Type: BEHAVIORAL; Name: Standard; Assigned to Arm(s): Standard
C: Arm Label: Control: Lifestyle counseling; Type: ACTIVE_COMPARATOR; Interventions: Other: Control: Lifestyle counseling | Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Other: Intervention group, Other: Control: Lifestyle counseling | Intervention Type: OTHER; Name: Intervention group; Assigned to Arm(s): Intervention group | Intervention Type: OTHER; Name: Control: Lifestyle counseling; Assigned to Arm(s): Control: Lifestyle counseling, Intervention group
D: Arm Label: Experimental: Group Sessions; Type: EXPERIMENTAL; Interventions: Behavioral: Group Sessions, Behavioral: Feedback, Behavioral: Self-monitoring | Arm Label: Active Comparator: Self-Monitoring; Type: EXPERIMENTAL; Interventions: Behavioral: Self-monitoring | Arm Label: Experimental: Feedback; Type: EXPERIMENTAL; Interventions: Behavioral: Feedback, Behavioral: Self-monitoring | Intervention Type: BEHAVIORAL; Name: Group Sessions; Assigned to Arm(s): Experimental: Group Sessions | Intervention Type: BEHAVIORAL; Name: Feedback; Assigned to Arm(s): Experimental: Feedback, Experimental: Group Sessions | Intervention Type: BEHAVIORAL; Name: Self-monitoring; Assigned to Arm(s): Active Comparator: Self-Monitoring, Experimental: Feedback, Experimental: Group Sessions

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: EVIDENT3 Study: A Randomized, Controlled Clinical Trial to Reduce Inactivity and Caloric Intake in Sedentary, Overweight People Using a Smartphone Application. Study Protocol.
Brief Summary: This is a randomized clinical trial aimed at obese and sedentary subjects aged 20 to 65 years selected in urban primary care centers of 5 centers (Spain). Its objective is to evaluate the effects of the addition of an ICT tool developed for the Smartphone application and a Smartband in support of behavioral and educational recommendations to reduce weight.


Options:
A: Arm Label: Cognitive app; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mobile Intervention for Lifestyle Eating/Exercise @ Stanford | Arm Label: Social app; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mobile Intervention for Lifestyle Eating/Exercise @ Stanford | Arm Label: Affect app; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mobile Intervention for Lifestyle Eating/Exercise @ Stanford | Arm Label: Nutrition app; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mobile Intervention for Lifestyle Eating/Exercise @ Stanford | Intervention Type: BEHAVIORAL; Name: Mobile Intervention for Lifestyle Eating/Exercise @ Stanford; Assigned to Arm(s): Affect app, Cognitive app, Nutrition app, Social app
B: Arm Label: Control: Lifestyle counseling; Type: ACTIVE_COMPARATOR; Interventions: Other: Control: Lifestyle counseling | Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Other: Intervention group, Other: Control: Lifestyle counseling | Intervention Type: OTHER; Name: Intervention group; Assigned to Arm(s): Intervention group | Intervention Type: OTHER; Name: Control: Lifestyle counseling; Assigned to Arm(s): Control: Lifestyle counseling, Intervention group
C: Arm Label: Behavioral intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral intervention to reduce sedentary time delivered via mobile smartphone | Intervention Type: BEHAVIORAL; Name: Behavioral intervention to reduce sedentary time delivered via mobile smartphone; Assigned to Arm(s): Behavioral intervention
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: text messages related to sedentary behaviour | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: text messages related to sedentary behaviour; Assigned to Arm(s): Intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 (Stoss Therapy) in Pediatric Patients Undergoing HSCT to Prevent Vitamin D Deficiency and Insufficiency During Transplant
Brief Summary: Research has suggested that children with sufficient vitamin D levels undergoing hematopoietic stem cell transplant (HSCT) have improved outcomes, including lower incidences of infection and graft-versus-host disease (GVHD), as well as overall improved survival. However, supplementation in children undergoing HSCT has shown to be a challenge using standard or aggressive supplementation strategies. The primary objective of this study is to determine the safety and efficacy of a single, high dose oral vitamin D (Stoss Therapy) at the start of transplant followed by maintenance supplementation in children undergoing HSCT.


Options:
A: Arm Label: Single, high dose oral vitamin D3; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D3, Dietary Supplement: Standard Vitamin D3 Supplementation | Arm Label: Standard Vitamin D Supplementation; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Standard Vitamin D3 Supplementation | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D3; Assigned to Arm(s): Single, high dose oral vitamin D3 | Intervention Type: DIETARY_SUPPLEMENT; Name: Standard Vitamin D3 Supplementation; Assigned to Arm(s): Single, high dose oral vitamin D3, Standard Vitamin D Supplementation
B: Arm Label: Vitamin D (10 microgram/day); Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D3 (cholecalciferol) | Arm Label: Vitamin D (20 microgram/day); Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D3 (cholecalciferol) | Arm Label: Placebo control; Type: PLACEBO_COMPARATOR; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D3 (cholecalciferol); Assigned to Arm(s): Vitamin D (10 microgram/day), Vitamin D (20 microgram/day)
C: Arm Label: 2000 IU per day vitamin D; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D3 - Cholecalciferol 2000 IU | Arm Label: 400 IU per day vitamin D; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vitamin D - Cholecalciferol 400 IU | Intervention Type: DRUG; Name: Vitamin D - Cholecalciferol 400 IU; Assigned to Arm(s): 400 IU per day vitamin D | Intervention Type: DRUG; Name: Vitamin D3 - Cholecalciferol 2000 IU; Assigned to Arm(s): 2000 IU per day vitamin D
D: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Drug: No supplementation | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: No supplementation; Assigned to Arm(s): 1 | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D; Assigned to Arm(s): 3

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Do Cardiac Health: Advanced New Generation Ecosystem - Phase 2
Brief Summary: The Do CHANGE service is designed for cardiac patients who could benefit from lifestyle change and a better disease management. The study aims to support patients with behavior change by providing them with devices and behavioral intervention in order to facilitate long-term behavior change.


Options:
A: Arm Label: A; Type: OTHER; Interventions: Other: A: Home-Based exercise after Cardiac Rehabilitation | Arm Label: B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: A: Home-Based exercise after Cardiac Rehabilitation; Assigned to Arm(s): A
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Do CHANGE | Arm Label: Care as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Do CHANGE; Assigned to Arm(s): Intervention
C: Arm Label: Center-based cardiac rehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Center-based cardiac rehabilitation | Arm Label: Home-based training with telemonitoring guidance; Type: EXPERIMENTAL; Interventions: Behavioral: Home-based training with telemonitoring guidance | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Center-based cardiac rehabilitation; Assigned to Arm(s): Center-based cardiac rehabilitation | Intervention Type: BEHAVIORAL; Name: Home-based training with telemonitoring guidance; Assigned to Arm(s): Home-based training with telemonitoring guidance
D: Arm Label: Current Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Care Transition Intervention; Type: EXPERIMENTAL; Interventions: Other: Structured Telephone / Remote Outpatient Monitoring | Intervention Type: OTHER; Name: Structured Telephone / Remote Outpatient Monitoring; Assigned to Arm(s): Care Transition Intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Do Cardiac Health: Advanced New Generation Ecosystem - Phase 2
Brief Summary: The Do CHANGE service is designed for cardiac patients who could benefit from lifestyle change and a better disease management. The study aims to support patients with behavior change by providing them with devices and behavioral intervention in order to facilitate long-term behavior change.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Do CHANGE | Arm Label: Care as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Do CHANGE; Assigned to Arm(s): Intervention
B: Arm Label: The Box; Type: EXPERIMENTAL; Interventions: Other: The Box | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: The Box; Assigned to Arm(s): The Box
C: Arm Label: Center-based cardiac rehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Center-based cardiac rehabilitation | Arm Label: Home-based training with telemonitoring guidance; Type: EXPERIMENTAL; Interventions: Behavioral: Home-based training with telemonitoring guidance | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Center-based cardiac rehabilitation; Assigned to Arm(s): Center-based cardiac rehabilitation | Intervention Type: BEHAVIORAL; Name: Home-based training with telemonitoring guidance; Assigned to Arm(s): Home-based training with telemonitoring guidance
D: Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Prehab Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Prehab Intervention | Intervention Type: BEHAVIORAL; Name: Prehab Intervention; Assigned to Arm(s): Prehab Intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of an Exercise-based Cardiac Rehabilitation Program 'Baduanjin-eight-silken-movement With Self-efficacy Building' for Patients With Chronic Heart Failure in Guangzhou, China (BESMILE-HF Study)
Brief Summary: Chronic heart failure (CHF) is a major and growing public health problem and poses economic burden on the society. There is a need for a safe, equipment-free, low-cost, and easily implemented exercise-based cardiac rehabilitation program for CHF patients in China. Baduanjin exercise, translated as 'eight silken movements', is one of the most common forms of traditional Chinese exercise and it could have value to be integrated into a exercise-based cardiac rehabilitation program for CHF patients, together with education, evaluation and consultancy. Accordingly, the BESMILE-HF program applying the Baduanjin exercise as the central component, has been developed in Guangdong Provincial Hospital of Chinese Medicine which is one of the largest hospitals of Chinese medicine in China. This project is to evaluate the efficacy and acceptability of BESMILE-HF program in patients with CHF in China, and it will be based on a randomized controlled trial and a qualitative study.


Options:
A: Arm Label: BESMILE-HF group; Type: EXPERIMENTAL; Interventions: Behavioral: BESMILE-HF program, Drug: Usual medications | Arm Label: Control; Type: OTHER; Interventions: Drug: Usual medications | Intervention Type: BEHAVIORAL; Name: BESMILE-HF program; Assigned to Arm(s): BESMILE-HF group | Intervention Type: DRUG; Name: Usual medications; Assigned to Arm(s): BESMILE-HF group, Control
B: Arm Label: Web-based physio; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Arm Label: Print-out exercise programme; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Print-out exercise programme, Web-based physio
C: Arm Label: Telerehabilitation programme; Type: EXPERIMENTAL; Interventions: Device: Telerehabilitation programme | Arm Label: Control group traditional rehabilitation; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Telerehabilitation programme; Assigned to Arm(s): Telerehabilitation programme
D: Arm Label: M2M; Type: EXPERIMENTAL; Interventions: Behavioral: M2M | Arm Label: M2Mplus; Type: EXPERIMENTAL; Interventions: Behavioral: M2M | Arm Label: Attention Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Attention Control | Intervention Type: BEHAVIORAL; Name: M2M; Assigned to Arm(s): M2M, M2Mplus | Intervention Type: BEHAVIORAL; Name: Attention Control; Assigned to Arm(s): Attention Control

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Physical Therapy and Deep Brain Stimulation in Parkinson Disease
Brief Summary: While deep brain stimulation of the subthalamic nucleus (STN-DBS) is commonly used to reduce tremor, muscle stiffness, and bradykinesia in people with Parkinson disease (PD), preliminary studies suggest balance may worsen and falls may increase after STN-DBS. Walking speed, known to be reduced in PD, typically improves after surgery; however, other important gait qualities may not improve. Given the potential for worsening balance and gait and increasing falls after surgery, it is imperative that researchers explore interventions that complement the positive effects of STN-DBS and delay worsening of balance and gait.

Physical therapy (PT) is reported to be effective in improving balance and walking in people with PD. However, there have been no studies to investigate how individuals with STN-DBS respond to PT. As such, it is unclear if exercise in the post-DBS population is safe, feasible, and effective. The purpose of this study is to examine the safety, feasibility, and efficacy of PT in people with PD with STN-DBS.

The investigators hypothesize that PT will be safe and feasible for people with PD with STN-DBS. Further, the investigators hypothesize that those assigned to PT group will demonstrate improvements in balance and gait while those assigned to the control group will demonstrate no change or a decline in balance and gait.


Options:
A: Arm Label: Group B; Type: PLACEBO_COMPARATOR; Interventions: Device: Libra Deep Brain Stimulation System | Arm Label: Group A; Type: EXPERIMENTAL; Interventions: Device: Libra Deep Brain Stimulation System | Intervention Type: DEVICE; Name: Libra Deep Brain Stimulation System; Assigned to Arm(s): Group A | Intervention Type: DEVICE; Name: Libra Deep Brain Stimulation System; Assigned to Arm(s): Group B
B: Arm Label: Physical Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Therapy | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Physical Therapy; Assigned to Arm(s): Physical Therapy
C: Arm Label: Early Multi-Ex-PD; Type: EXPERIMENTAL; Interventions: Behavioral: Balance & Strengthening Exercises | Arm Label: Late Multi-Ex-PD; Type: EXPERIMENTAL; Interventions: Behavioral: Balance & Strengthening Exercises | Intervention Type: BEHAVIORAL; Name: Balance & Strengthening Exercises; Assigned to Arm(s): Early Multi-Ex-PD, Late Multi-Ex-PD
D: Arm Label: Memantine; Type: EXPERIMENTAL; Interventions: Drug: Memantine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Memantine; Assigned to Arm(s): Memantine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy and Safety of BB-12 Supplemented Strawberry Yogurt For Healthy Children on Antibiotics
Brief Summary: Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. One of the most common indications for probiotic treatment is the prevention of antibiotic-associated diarrhea (AAD). Unfortunately, many probiotic products used for AAD are not supported by rigorous independent research, and often results in non-evidence-based usage. The overarching objective is to move research forward for the most well-studied Bifidobacterium strain. The primary aim is to test the efficacy of high dose, BB-12-supplemented yogurt in preventing AAD, compared to yogurt without BB-12, in children receiving antibiotics. Other aims are to further assess the safety of yogurt supplemented with BB-12, and to carry out longitudinal community structure and gene expression analysis of fecal microbiota to evaluate the impact of high dose BB-12 in a pediatric population receiving antibiotics. The microbiota includes hundreds of species, and its disruption is hypothesized to be an important factor in the development of AAD.


Options:
A: Arm Label: Probiotics; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Probiotic capsules | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo capsules | Intervention Type: DIETARY_SUPPLEMENT; Name: Probiotic capsules; Assigned to Arm(s): Probiotics | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo capsules; Assigned to Arm(s): Placebo
B: Arm Label: BB-12; Type: EXPERIMENTAL; Interventions: Biological: Bifidobacterium animalis subsp. lactis BB-12 | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Control | Intervention Type: BIOLOGICAL; Name: Bifidobacterium animalis subsp. lactis BB-12; Assigned to Arm(s): BB-12 | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Lactobacillus GG | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Lactobacillus GG; Assigned to Arm(s): 1 | Intervention Type: DIETARY_SUPPLEMENT; Name: placebo; Assigned to Arm(s): 2
D: Intervention Type: DIETARY_SUPPLEMENT; Name: Lactobacillus reuteri (DSM 17938); Assigned to Arm(s): N/A

Answer: B